| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director | EVP And Chief Medical Officer
4 companies
Bedrosian Camille L is a Chief Medical Officer at AMLX with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 364 | $113.67 | $41,375.88 | -0.9% | -26.2% | -50.3% | |
| Apr 15, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sale+OE | 5,000 | $109.09 | $545,450.00 | -11.3% | -22.7% | -22.1% | |
| Mar 1, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 4,543 | $138.18 | $627,751.74 | -10.4% | - | - | |
| Jan 30, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 2,243 | $140.36 | $314,827.48 | -6.3% | - | - | |
| Jan 15, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sale+OE | 25,000 | $139.18 | $3,479,500.00 | -41.1% | - | - | |
| Oct 14, 2020 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 262 | $88.00 | $23,056.00 | -0.7% | - | - |